Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 14 de 14
Filter
Add more filters










Publication year range
1.
Ann Endocrinol (Paris) ; 55(2): 109-20, 1994.
Article in English | MEDLINE | ID: mdl-7802428

ABSTRACT

Transforming growth factor-beta (TGF-beta) has a dual effect on the proliferation of joint chondrocytes. In medium with a low serum concentration, it inhibits cell growth, while in medium supplemented with 10% fetal calf serum it stimulates cell growth. This stimulation leads to a higher replication rate an a larger number of cells in the G2/M phase of the cell cycle. Since these cells have already replicated their DNA, they can begin mitosis when stimulated by a EGF type factor. This mechanism involves the systems of the TGF-beta receptors which appear to vary with the cell cycle. In addition, a glycane inositophosphate may play a role as a second messenger for TGG-beta in this action. Finally, TGF-beta cannot restore the chondrocyte phenotype in dedifferentiated cells nor limit the dedifferentiation process. It exerts a opposing effect to the deleterious effects of interleukin-1 by inhibiting the expression of the receptors of this cytokine at the level of transcription. These in vitro effects would suggest that TGF-beta plays an important role in the repair potentiality of joint cartilage especially in arthrosis. In vivo studies are however necessary to verify this hypothesis.


Subject(s)
Cartilage, Articular/cytology , Transforming Growth Factor beta/pharmacology , Animals , Cell Division/drug effects , Extracellular Matrix/metabolism , G2 Phase , Interleukin-1/antagonists & inhibitors , Rabbits , Receptors, Transforming Growth Factor beta/metabolism
2.
J Cell Physiol ; 150(2): 291-8, 1992 Feb.
Article in English | MEDLINE | ID: mdl-1346400

ABSTRACT

This study was undertaken to gain more insight into the mechanism whereby TGF-beta influences the cell cycle progression of cultured rabbit articular chondrocytes. Using proliferating chondrocytes in fetal calf serum-containing medium, we have previously shown that TGF-beta induced a recruitment of cells at the end of the S phase (G2/M) observed 24 h after addition. The delayed cells may then be released, producing a proliferative effect at 48 h, provided a substantial amount of FCS (10%) is present in the medium. Otherwise, in low level of serum (2% FCS, for example), only inhibition of cell proliferation is observed. In chondrocytes synchronized in S phase by a thymidine block, we investigated here the time-course incorporation of [3H]-thymidine into DNA, the cell cycle traverse by flow cytofluorometric study of DNA content, the expression of PCNA (Proliferating Cell Nuclear Antigen), and cAMP levels. The data demonstrate that TGF-beta provoked a decrease of cAMP content (0.5-1 h) followed by an enhancement of the DNA synthesis rate (4 h) which was detectable through cytofluorometric analysis and [3H]-thymidine labeling and correlated with the PCNA expression. In contrast, addition of cAMP analogues to the cultures resulted in an inhibition of replication rate. We also showed that pertussis toxin produced a decrease of the DNA synthesis rate, in a transient manner and only in the presence of TGF-beta. All these results suggest that TGF-beta may accelerate the replication process of cyclized chondrocytes, making then accumulate at the G2/M boundary, via a mechanism that could involve the adenylate cyclase activity and a Gi-protein. The factor might be responsible for producing a pool of cells having already replicated their DNA and therefore capable of re-entering the cell cycle without delay. This cell population could serve as a tissue reserve able to induce a mitosis wave when necessary--for example, in the repair of tissue damage.


Subject(s)
Cartilage, Articular/cytology , Cell Cycle/drug effects , Transforming Growth Factor beta/pharmacology , Adenylate Cyclase Toxin , Animals , Cholera Toxin/pharmacology , Cyclic AMP/metabolism , DNA Replication/drug effects , Flow Cytometry , In Vitro Techniques , Nuclear Proteins/metabolism , Pertussis Toxin , Proliferating Cell Nuclear Antigen , Rabbits , Virulence Factors, Bordetella/pharmacology
3.
Biochim Biophys Acta ; 1093(2-3): 196-206, 1991 Jul 10.
Article in English | MEDLINE | ID: mdl-1863600

ABSTRACT

The effect of transforming growth factor-beta (TGF-beta, 1 ng/ml) on proteoglycan synthesis by rabbit articular chondrocytes in culture was studied in the presence of fetal bovine serum. Exposure of confluent cells for 24 h to the factor resulted in a marked increase of 35S-labeled sulfate incorporation in the newly synthesized proteoglycans (PG), as estimated by glycosaminoglycan (GAG) radioactivity (+58%). The onset was observed 6 h after addition of the factor but was significant after 12 h. TGF-beta also enhanced the uptake of [35S]sulfate by chondrocytes, but had no effect on the release of PG by these cells. The effect of TGF-beta on the distribution of PG between the medium and the cell layer was shown to be dependent on the serum concentration in the medium: the relative proportion of cell-layer associated GAG of TGF-beta-treated cells decreased with increasing concentration of fetal bovine serum. The proportion of aggregated PG, the hydrodynamic size of PG monomers and GAG chains were not modified by TGF-beta, but the relative distribution of disaccharides 6- and 4-sulfate in GAG chains was altered by the factor: the proportion of chondroitin 6-sulfate (C6S) was decreased while that of chondroitin 4-sulfate (C4S) was augmented in presence of TGF-beta, leading to a decrease of the ratio C6S/C4S (-11 to -22%, P less than 0.01). The present study indicates that TGF-beta promotes the synthesis of a modified extracellular matrix in cultured articular chondrocytes. This mechanism could be relevant to some aspects of cartilage repair in osteoarticular diseases.


Subject(s)
Cartilage, Articular/metabolism , Proteoglycans/metabolism , Transforming Growth Factor beta/physiology , Animals , Cells, Cultured , Chromatography, Gel , Chromatography, Ion Exchange , Glycosaminoglycans/biosynthesis , Glycosaminoglycans/chemistry , Glycosaminoglycans/metabolism , Kinetics , Phenotype , Proteoglycans/biosynthesis , Rabbits , Sulfates/metabolism
4.
Int J Tissue React ; 12(1): 21-31, 1990.
Article in English | MEDLINE | ID: mdl-2117000

ABSTRACT

The production of collagen and glycosaminoglycans (GAG) was studied in cultured human synovial cells exposed to four cytokines, alone or in dual combination, namely interleukin-1 (IL-1), tumor necrosis factor-alpha (TNF-alpha), interferon-gamma (IFN-gamma) and transforming growth factor-beta (TGF-beta). Among these cytokines, only TGF-beta (0.1-10 ng/ml) induced a significant and dose-dependent increase of collagen synthesis in a 24-h incubation. This effect was reversed when the factor was associated with either IL-1 beta (100-500 pg/ml), TNF-alpha (1-100 ng/ml) or IFN-gamma (100 U/ml). Except IFN-gamma which clearly inhibits the collagen production, the other cytokines IL-1 and TNF-alpha were not very effective when tested separately, although they generally induced a small reduction in collagen amount. IL-1 beta and TNF-alpha were found to be more efficient than TGF-beta in stimulating the production of GAG by the synovial cells. IFN-gamma exerted an antagonistic effect on the TGF-beta-induced stimulation of GAG synthesis. TNF-alpha and IL-1 beta were shown to have an additive effect on that production. The results indicate that interactions between cytokines present in the inflamed synovial tissue may modulate their respective actions and thus introduce differentials in their effect on collagen and GAG metabolism which are responsible for the alterations of synovial extracellular matrix in rheumatoid arthritis.


Subject(s)
Biological Factors/pharmacology , Collagen/biosynthesis , Glycosaminoglycans/biosynthesis , Cells, Cultured , Cytokines , Drug Interactions , Humans , Interferon-gamma/pharmacology , Interleukin-1/pharmacology , Synovial Membrane/cytology , Synovial Membrane/drug effects , Synovial Membrane/metabolism , Transforming Growth Factors/pharmacology , Tumor Necrosis Factor-alpha/pharmacology
6.
FEBS Lett ; 236(1): 47-52, 1988 Aug 15.
Article in English | MEDLINE | ID: mdl-3165348

ABSTRACT

Tumor necrosis factor (TNF) caused inhibition of collagen production by confluent cultures of human dermal fibroblasts in a dose-dependent manner. Concomitant increase of prostaglandin E2 release was observed as a result of TNF-induced cell activation. However, a blockade of the cyclooxygenase pathway of arachidonate metabolism by indomethacin did not abrogate the inhibitory effect of TNF on collagen synthesis, suggesting that this effect could be independent of prostaglandin metabolism. Gel electrophoresis of the newly synthesized macromolecules from the culture media showed that both type I and type III collagens as well as fibronectin were affected by the inhibition. Electrophoresis of cell layer-associated proteins demonstrated that the reduction in amounts of collagen and fibronectin in the medium did not result from an intracellular accumulation of these macromolecules. Production of procollagens was reduced in parallel to that of collagens, suggesting that the effect of TNF is exerted before the processing steps of procollagens. These results clearly show that TNF could play a role in modulation of matrix deposition by fibroblasts during inflammatory processes.


Subject(s)
Collagen/biosynthesis , Fibronectins/biosynthesis , Skin/drug effects , Tumor Necrosis Factor-alpha/pharmacology , Cell Division , Cells, Cultured , Dinoprostone , Electrophoresis, Polyacrylamide Gel , Fibroblasts , Humans , Indomethacin/pharmacology , Prostaglandins E/biosynthesis , Recombinant Proteins/pharmacology , Skin/cytology , Skin/metabolism
7.
FEBS Lett ; 231(1): 125-9, 1988 Apr 11.
Article in English | MEDLINE | ID: mdl-3360117

ABSTRACT

The role of indomethacin in the regulation of extracellular matrix synthesis was studied in dermal fibroblast cultures. Indomethacin (10 microM) blocked totally the prostaglandin secretion and markedly increased the synthesis of collagen. In parallel, measurement of fibronectin, type I and type III procollagen mRNA levels showed a substantial increase under the action of indomethacin. On the other hand, indomethacin did not modify the mRNA levels of dermatan sulfate proteoglycan core protein. Measurement of collagen production estimated as the amount of collagenase digestible protein and by specific radioimmunoassay indicated a good correlation with the corresponding mRNA levels. These results suggest that indomethacin can regulate the extracellular matrix deposition at a transcriptional level.


Subject(s)
Chondroitin Sulfate Proteoglycans/genetics , Chondroitin/analogs & derivatives , Collagen/genetics , Dermatan Sulfate/genetics , Extracellular Matrix/metabolism , Genes/drug effects , Indomethacin/pharmacology , Procollagen/genetics , Proteoglycans/genetics , Skin/metabolism , Transcription, Genetic/drug effects , Cells, Cultured , Fibroblasts/drug effects , Fibroblasts/metabolism , Fibronectins/genetics , Humans , RNA, Messenger/genetics , Skin/drug effects
8.
Int J Tissue React ; 10(3): 121-32, 1988.
Article in English | MEDLINE | ID: mdl-3147268

ABSTRACT

Arthritic-rendered rabbits were treated in vivo with 50 mg/kg D-penicillamine (D-Pen) daily during 4 months. Glycosaminoglycan (GAG) synthesis by synovial fibroblast cultures from D-Pen treated and untreated normal or arthritic animals was studied. Cells from arthritic-rendered animals synthesized hyaluronic acid (HA) at the same rate as cells isolated from control rabbits. When D-Pen was administered to arthritic-rendered rabbits, it significantly inhibited GAG production by fibroblasts. The hyaluronate synthetase activity determined on synovial fibroblast homogenates, however, was not modified whatever the treatment undergone by the rabbits. Moreover, synovial fibroblasts from arthritic rabbits treated or not with D-Pen generally synthesized HA with a high molecular weight similar to that produced by D-Pen treated or untreated control animals.


Subject(s)
Arthritis, Experimental/drug therapy , Arthritis/drug therapy , Glycosaminoglycans/biosynthesis , Glycosyltransferases , Membrane Proteins , Penicillamine/therapeutic use , Synovial Membrane/drug effects , Transferases , Xenopus Proteins , Animals , Arthritis, Experimental/metabolism , Cells, Cultured , Chromatography, Affinity , Chromatography, DEAE-Cellulose , Fibroblasts/drug effects , Fibroblasts/metabolism , Glucuronosyltransferase/analysis , Hyaluronan Synthases , Male , Molecular Weight , Pronase/metabolism , Rabbits , Synovial Membrane/cytology , Synovial Membrane/metabolism
9.
Biochim Biophys Acta ; 927(1): 34-42, 1987 Jan 19.
Article in English | MEDLINE | ID: mdl-3098300

ABSTRACT

Cultured human synovial cells treated with an interleukin-1-like mononuclear cell factor incorporated more 35S in proteoglycans than control cultures, but the radioactivity distribution between medium and cell layer was not modified. Proteoglycans were synthesized essentially in monomeric form and the mononuclear cell factor increased the molecular weight of these monomers. The [3H]hexosamine/[14C]serine ratio in purified proteoglycans on the one hand, and the study of [35S]glycosaminoglycan molecular weight, on the other hand, indicated that this increase is not modulated through enhanced synthesis of core protein but by an increase in the glycosaminoglycan chain length. After enzyme hydrolysis, dermatan sulfate (62% of the total glycosaminoglycans) and chondroitin 4/6-sulfate (30%) were found to be the major glycosaminoglycans synthesized by cultured synovial cells, and the existence of 8% heparan sulfate was evidenced by nitrous acid treatment. In the presence of the mononuclear cell factor, the dermatan sulfate synthesis was decreased (47%), with a concomitant increase of chondroitin sulfate synthesis (45%).


Subject(s)
Proteins/pharmacology , Proteoglycans/biosynthesis , Synovial Membrane/metabolism , Aged , Cells, Cultured , Chondroitin Sulfates/biosynthesis , Female , Glycosaminoglycans/biosynthesis , Hexosamines/metabolism , Humans , Male , Middle Aged , Molecular Weight , Monokines , Serine/metabolism , Synovial Membrane/drug effects
10.
Biochem Biophys Res Commun ; 134(2): 539-49, 1986 Jan 29.
Article in English | MEDLINE | ID: mdl-3484951

ABSTRACT

A partially purified monocyte factor, with Interleukin-1 properties (MCF/IL-1), enhances the proteoglycan synthesis of human neonatal articular chondrocytes in culture, and changes the repartition of these macromolecules between medium and cell layer. The size of the proteoglycan monomers, the length of the glycosaminoglycan chains and the respective levels of chondroitin-6-sulfate, chondroitin-4-sulfate and non sulfated chondroitin remain unchanged under MCF/IL-1 exposures. The addition of indomethacin reduces the stimulation effect by 60-70% only, suggesting that the MCF/IL-1 action is partially dependent on prostaglandins but seems also related to mechanisms distinct from the cyclooxygenase pathway.


Subject(s)
Cartilage, Articular/metabolism , Interleukin-1/pharmacology , Monocytes/physiology , Proteoglycans/biosynthesis , Cartilage, Articular/cytology , Cells, Cultured , Glycosaminoglycans/analysis , Humans , Indomethacin/pharmacology , Molecular Weight , Monocytes/analysis , Monokines , Prostaglandins/physiology , Proteins/pharmacology , Proteoglycans/analysis
11.
Exp Cell Res ; 160(1): 9-18, 1985 Sep.
Article in English | MEDLINE | ID: mdl-3930273

ABSTRACT

Treatment of cultured human synovial cells with a mononuclear cell factor (MCF) enhanced their ability to synthesize glycosaminoglycans (GAG), but GAG repartition between extracellular, pericellular and intracellular compartments was found to be the same as in control. Hyaluronic acid (HA) production, which represents 80-90% of all secreted GAG, was stimulated 2 1/2-3-fold, but the HA molecular weight was not modified. The MCF increased the hyaluronate synthetase activity of synovial cells in similar proportions. Actinomycin D inhibited the increase in hyaluronate synthetase activity produced by MCF, indicating that this increase involves new synthesis of mRNA. Stimulation of both HA synthesis and hyaluronate synthetase activity by MCF was suppressed by 10(-4)-10(-5) M indomethacin (an inhibitor of cyclo-oxygenase), suggesting that MCF effect is prostaglandin-dependent.


Subject(s)
Glycosyltransferases , Hyaluronic Acid/biosynthesis , Membrane Proteins , Proteins/pharmacology , Synovial Membrane/metabolism , Transferases , Xenopus Proteins , Aged , Cells, Cultured , Dactinomycin/pharmacology , Female , Glucosamine/metabolism , Glucuronosyltransferase/metabolism , Humans , Hyaluronan Synthases , Indomethacin/pharmacology , Male , Middle Aged , Molecular Weight , Monokines , Synovial Membrane/drug effects , Synovial Membrane/enzymology
12.
Pathol Biol (Paris) ; 33(5 Pt 2): 639-41, 1985 Jun.
Article in French | MEDLINE | ID: mdl-3003659

ABSTRACT

The influence of dilution of povidone-iodine solutions on virucidal activity against poliovirus type 1 was investigated. After exposure to different concentrations of povidone-iodine, the reduction in virus titer was determined after separating the antiseptic by gel filtration. Diluted preparations (0.5 and 0.25%) achieved a greater reduction in virus titer (10(5) in one hour) than the 5% stock solution (10(3)). Moreover, dilute solutions exhibited a faster virucidal activity.


Subject(s)
Poliovirus/drug effects , Povidone-Iodine/pharmacology , Povidone/analogs & derivatives , Microbial Sensitivity Tests , Solutions
13.
Pathol Biol (Paris) ; 32(5 Pt 2): 636-9, 1984 Jun.
Article in French | MEDLINE | ID: mdl-6087252

ABSTRACT

The authors propose a method for determining the virucidal potency of antiseptics, in which separation of antiseptic from virus is achieved by filtration through a gel of Sephadex LH20. The antiseptic is trapped within the gel while the virus passes through. Thus, the cytotoxic effect of the antiseptic, which usually hinders virus titration, is eliminated. Two filtration devices were developed: one is a polypropylene syringe, and the other is made of stainless steel. Determination of the effect of four products on poliovirus type I shows that this method allows classification of their activities.


Subject(s)
Anti-Infective Agents, Local/pharmacology , Viruses/drug effects , Anti-Infective Agents, Local/isolation & purification , Chromatography, Gel/methods , Poliovirus/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL
...